Ausgabe 11-12/2002
Inhalt (12 Artikel)
Adjuvant immunotherapy for solid tumors: from promise to clinical application
Simone Mocellin, Carlo R. Rossi, Mario Lise, Francesco M. Marincola
Linomide administration following bone marrow transplantation in mice
Lola Weiss, Ali Abdul-Hai, Yoel Shufaro, Shoshanna Reich, Shimon Slavin
The combination of a chemokine, cytokine and TCR-based T cell stimulus for effective gene therapy of cancer
Stephane Paul, Etienne Regulier, Yves Poitevin, Horst Hormann, Bruce R. Acres
Mucin gene (MUC1) transfected dendritic cells as vaccine: results of a phase I/II clinical trial
Gabriele Pecher, Arnt Häring, Lothar Kaiser, Eckhard Thiel
Analysis of the antibody repertoire of lymphoma patients
Shaoming Huang, Klaus-Dieter Preuss, Xiaoxun Xie, Evi Regitz, Michael Pfreundschuh
Phase I/II study of sequential chemoimmunotherapy (SCIT) for metastatic melanoma: outpatient treatment with dacarbazine, granulocyte-macrophage colony-stimulating factor, low-dose interleukin-2, and interferon-alpha
Gerard Groenewegen, Andries Bloem, Gijsbert C. de Gast
Calcitonin-specific antitumor immunity in medullary thyroid carcinoma following dendritic cell vaccination
Matthias Schott, Joachim Feldkamp, Melanie Klucken, Guido Kobbe, Werner A. Scherbaum, Jochen Seissler
Therapeutic vaccination against metastatic renal cell carcinoma by autologous dendritic cells: preclinical results and outcome of a first clinical phase I/II trial
Angela Märten, Dimitri Flieger, Sabine Renoth, Silvia Weineck, Peter Albers, Markus Compes, Björn Schöttker, Carsten Ziske, Steffen Engelhart, Peter Hanfland, Ludmila Krizek, Cora Faber, Alexander von Ruecker, Stefan Müller, Tilman Sauerbruch, Ingo G. Schmidt-Wolf
41.8°C whole body hyperthermia as an adjunct to chemotherapy induces prolonged T cell activation in patients with various malignant diseases
Djordje Atanackovic, Axel Nierhaus, Michael Neumeier, Dieter K. Hossfeld, Susanna Hegewisch-Becker
Efficient carcinoma cell killing by activated polymorphonuclear neutrophils targeted with an Ep-CAM×CD64 (HEA125×197) bispecific antibody
Christof Schweizer, Gudrun Strauss, Matthias Lindner, Alexander Marmé, Yashwant M. Deo, Gerhard Moldenhauer
Enhanced induction of human WT1-specific cytotoxic T lymphocytes with a 9-mer WT1 peptide modified at HLA-A*2402-binding residues
Akihiro Tsuboi, Yoshihiro Oka, Keiko Udaka, Masaki Murakami, Tomoki Masuda, Akiko Nakano, Hiroko Nakajima, Masaki Yasukawa, Akio Hiraki, Yusuke Oji, Manabu Kawakami, Naoki Hosen, Tatsuya Fujioka, Fei Wu, Yuki Taniguchi, Sumiyuki Nishida, Momotaro Asada, Hiroyasu Ogawa, Ichiro Kawase, Haruo Sugiyama
Synopsis of the 4th Walker's Cay Meeting on Cancer Vaccines, 7–10 March 2002
Malcolm S. Mitchell, Martin W. Kast